Jitesh Chauhan - Concepedia

Author

Jitesh Chauhan

Guy's and St Thomas' NHS Foundation Trust ORCID

Also Known As

Chauhan, Jitesh, Jitesh Chauhan

Publications

720

Citations

H-Index

Concepts

All Affiliations

Guy's and St Thomas' NHS Foundation Trust King's College London Breast Cancer Now Guy's Hospital University College London

About

Jitesh Chauhan is an author at Guy's and St Thomas' NHS Foundation Trust specializing in tumor immunity, humoral immunity, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	42
2	Immunology	2	2	42
3	Allergy	1	1	18
4	Cell Biology	1	1	24
5	Autoimmunity	1	1	24

Jitesh Chauhan

Publications

295

Citations

H-Index

Page 1

	Year	Citations
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes Heather J. Bax, Jitesh Chauhan, Chara Stavraka, British Journal of Cancer	2022	71
Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome Heather J. Bax, Jitesh Chauhan, Chara Stavraka, Cells	2020	45
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4 Jitesh Chauhan, Melanie Grandits, Lais C. G. F. Palhares, Nature Communications	2023	37
B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma Silvia Crescioli, Isabel Corrêa, Joseph Ng, Nature Communications	2023	34
Enriched circulating and tumor-resident TGF-β <sup>+</sup> regulatory B cells in patients with melanoma promote FOXP3 <sup>+</sup> Tregs R. J. C. Harris, Zena Willsmore, Roman Laddach, OncoImmunology	2022	33
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial James Spicer, Bristi Basu, Ana Montes, Nature Communications	2023	33
IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype Mano Nakamura, E. Amiri Souri, Gabriel Osborn, Cancers Trimeric FcεriIge Activates MonocytesImmune RegulationImmunologyImmunologic Mechanism	2020	24
Abstract CT141: Phase 1 trial of MOv18, a first-in-class IgE antibody therapy for cancer James Spicer, Bristi Basu, Ana Montes, Cancer Research Ige AntibodiesImmunologyImmunoeditingImmune Cell TherapyImmunotherapy	2020	18

Page 1